SlideShare a Scribd company logo
1 of 10
Bone Marrow Biopsy
 Focal involvement by small B-cell neoplasm without
significant plasmacytic differentiation (CD3-, CD20+,
PAX5+, kappa IHC-, lambda IHC-, CD5-, CD10-,
BCL6-, BCL2+, cyclin D1-, IgD-, Ki67 low)
Courtesy of T Pongpruttipan, MD.
Review of Colonic Polyp Biospy Tissue
HE
CD20
HE HE
Courtesy of T Pongpruttipan, MD.
Final Pathological Diagnosis
 Involvement by small B-cell lymphoid neoplasm
with CD10+, BCL2+, BCL6- phenotype. No
evidence of large cell involvement.
 Some small and large cells showed large
aggregates with infiltrative growth pattern.
 IMP: follicular lymphoma with focus of large cell
transformation
 DDx
 DLBCL with accompanying follicular lymphoma
 Follicular lymphoma, grade 3/3 (focal) in the
background of follicular lymphoma, low grade
Colorectal Lymphoma
 A type of extranodal
lymphoma involving
GI tract
 Primary GI lymphoma
 Stomach 40-50%
 Small bowel 20-30%
 Colon and rectum
10-20%
 Primary GI lymphoma
 No palpable, superficial LN
 No enlarged mediastinal LN
on CXR
 Normal WBC (No and
differential count)
 Only regional LN involved
 No involvement of liver and
spleen
Dawson IM, et al. Primary malignant lymphoid tumours of the intestinal tract. Report of 37
cases with a study of factors influencing prognosis. Br J Surg 1961;49:80-9.
Staging of Lymphoma
Musshoff Modifications to Ann Arbor Staging
System for Extranodal Lymphoma
Stage
I or IE Single lymphatic organ or extranodal site
II Two or more lymphatic regions on the same site of
the diaphragm or a single extranodal organ and
lymph node involvement at the same site of
diaphragm
II1 Regional lymph node involved
II2 Distant lymph node involved
III Lymph node involved on both sides of diaphragm
IV Disseminated disease with involvement of bone
marrow, liver, etc
Musshoff K. Strahlentherapie 1977;153:218-21.
Boot H. Best Pract Res Clin Gastroenterol 2010;24(1):3-12.
Common Types in Colorectal NHL
 DLBCL 60%
 de novo
 Transformation from
CLL, follicular
lymphoma, MALT
 MALT 15%%
 Burkitt 15
 Recent report from
Terada T, Japan
 37 cases of GI
lymphoma
 M:F 20:17
 Median age 69 yr (46-
89)
 Types
 Gastric 25 (68%)
 Small bowel 6 (16%)
 Colon 6 (16%)
Terada T. Gastrointestinal malignant lymphoma: a pathologic study of 37 cases in a
single Japanese institution. Am J Blood Res 2012;2(3):194-200.
Gastrointestinal Lymphoma
 Types
 B-cell 35 (95%)
 T-cell 2 (5%)
 Gastric NHL 25
 DLBCL 11
 MALT 14
 Small intestine
 DLBCL 4
 PTCL 2
 Colon 6
 DLBCL 5
 FL 1
 Clinical diagnosis of colon
NHL at first
 GIST 1
 Colon carcinoma 4
 Colon polyp 1
 No cases of
 Hodgkin lymphoma
 Burkitt lymphoma
 Mantle cell lymphom
Terada T. Gastrointestinal malignant lymphoma: a pathologic study of 37 cases in a
single Japanese institution. Am J Blood Res 2012;2(3):194-200.
Primary FL of GI tract:
Massachusetts General Hospital, 1995-2010
 Excluded cases
 History of FL outside
GI tract
 Widespread
lymphoma
 Distant nodal disease
within 6 months
 Multifocal diseases
 Splenic involvement
 FL in transformation
Misdraji J, et al. Primary
follicular lymphoma of the
gastrointestinal tract. Am J
Surg Pathol 2011;35:1255-63.
Presenting Symptoms/ Finding
 Symptoms
 Abdominal pain and
nausea, vomiting (12),
 bowel obstruction
 Intussuspection (1)
 Incidental finding (13)
on investigation of
 Reflux symptoms or
Barrett esophagus
 Screening for
colorectal cancer
 Resection of sigmoid
carcinoma
 Macroscopic findings
 White patches or
plaques
 Mucosal nodularity or
granularity
 Nodules
 Polyp (1, 2, 3)
 Submucosal mass
 Thickening of wall or
folds
Misdraji J, et al. Primary follicular lymphoma of the gastrointestinal
tract. Am J Surg Pathol 2011;35:1255-63.

More Related Content

What's hot

Non hodgkin lymphoma
Non hodgkin lymphomaNon hodgkin lymphoma
Non hodgkin lymphoma
prushton11
 
non-hodgkin’s-lymphoma
non-hodgkin’s-lymphomanon-hodgkin’s-lymphoma
non-hodgkin’s-lymphoma
Chandan N
 
Malignant Diseases Lymphatics & Soft Tissue #3
Malignant Diseases Lymphatics & Soft Tissue #3Malignant Diseases Lymphatics & Soft Tissue #3
Malignant Diseases Lymphatics & Soft Tissue #3
guest3757e6
 
pediatric lymphomas
pediatric lymphomaspediatric lymphomas
pediatric lymphomas
siti hamidah
 
Case Study for MNT, 12/2009
Case Study for MNT, 12/2009Case Study for MNT, 12/2009
Case Study for MNT, 12/2009
barashe1
 
medicine.Lymphomas.(dr.sabir)
medicine.Lymphomas.(dr.sabir)medicine.Lymphomas.(dr.sabir)
medicine.Lymphomas.(dr.sabir)
student
 

What's hot (20)

Hodgkin lymphoma db.pptx
Hodgkin lymphoma db.pptxHodgkin lymphoma db.pptx
Hodgkin lymphoma db.pptx
 
Non hodgkin lymphoma
Non hodgkin lymphomaNon hodgkin lymphoma
Non hodgkin lymphoma
 
Hodgkin's lymphoma
Hodgkin's lymphomaHodgkin's lymphoma
Hodgkin's lymphoma
 
non-hodgkin’s-lymphoma
non-hodgkin’s-lymphomanon-hodgkin’s-lymphoma
non-hodgkin’s-lymphoma
 
Hodgkins lymphoma history, physical exam and management
Hodgkins lymphoma history, physical exam and managementHodgkins lymphoma history, physical exam and management
Hodgkins lymphoma history, physical exam and management
 
Indolent non hodgkins lymphoma
Indolent non hodgkins lymphomaIndolent non hodgkins lymphoma
Indolent non hodgkins lymphoma
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Malignant Diseases Lymphatics & Soft Tissue #3
Malignant Diseases Lymphatics & Soft Tissue #3Malignant Diseases Lymphatics & Soft Tissue #3
Malignant Diseases Lymphatics & Soft Tissue #3
 
pediatric lymphomas
pediatric lymphomaspediatric lymphomas
pediatric lymphomas
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Lymphoma in children Dr G.Rajkumar
Lymphoma in children Dr G.RajkumarLymphoma in children Dr G.Rajkumar
Lymphoma in children Dr G.Rajkumar
 
HSCT for Pediatric Lymphoma
HSCT for Pediatric LymphomaHSCT for Pediatric Lymphoma
HSCT for Pediatric Lymphoma
 
Bohomolets Oncology Lecture Methodical #3
Bohomolets Oncology Lecture Methodical #3Bohomolets Oncology Lecture Methodical #3
Bohomolets Oncology Lecture Methodical #3
 
Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)
Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)
Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)
 
Case Study for MNT, 12/2009
Case Study for MNT, 12/2009Case Study for MNT, 12/2009
Case Study for MNT, 12/2009
 
Lymphoma
Lymphoma Lymphoma
Lymphoma
 
medicine.Lymphomas.(dr.sabir)
medicine.Lymphomas.(dr.sabir)medicine.Lymphomas.(dr.sabir)
medicine.Lymphomas.(dr.sabir)
 
A Case of Hodgkin's Disease
A Case of Hodgkin's DiseaseA Case of Hodgkin's Disease
A Case of Hodgkin's Disease
 
Seminar nhl
Seminar nhlSeminar nhl
Seminar nhl
 
Lymphoma
Lymphoma Lymphoma
Lymphoma
 

Similar to DIAGNOSTIC AND TREATMENT DILEMMAS IN NHL=PART 2

Molecular pathology of lymphoma by dr ramesh
Molecular pathology of  lymphoma by dr ramesh Molecular pathology of  lymphoma by dr ramesh
Molecular pathology of lymphoma by dr ramesh
Ramesh Purohit
 
Non Hodgkin Lymphoma treatment update (1).pptx
Non Hodgkin Lymphoma treatment update (1).pptxNon Hodgkin Lymphoma treatment update (1).pptx
Non Hodgkin Lymphoma treatment update (1).pptx
DoQuyenPhan1
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
Shimaa Abdallah
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
Manoj Toshniwal
 

Similar to DIAGNOSTIC AND TREATMENT DILEMMAS IN NHL=PART 2 (20)

Recent advances in upper gastrointestinal lymphomas (1) (1)
Recent advances in upper gastrointestinal lymphomas (1) (1)Recent advances in upper gastrointestinal lymphomas (1) (1)
Recent advances in upper gastrointestinal lymphomas (1) (1)
 
Lymphoma gi
Lymphoma giLymphoma gi
Lymphoma gi
 
GI Lymphoma
GI LymphomaGI Lymphoma
GI Lymphoma
 
NHL.pptx
NHL.pptxNHL.pptx
NHL.pptx
 
Molecular pathology of lymphoma by dr ramesh
Molecular pathology of  lymphoma by dr ramesh Molecular pathology of  lymphoma by dr ramesh
Molecular pathology of lymphoma by dr ramesh
 
Non Hodgkin Lymphoma treatment update (1).pptx
Non Hodgkin Lymphoma treatment update (1).pptxNon Hodgkin Lymphoma treatment update (1).pptx
Non Hodgkin Lymphoma treatment update (1).pptx
 
Chronic Lymphatic Leukaemia
Chronic Lymphatic LeukaemiaChronic Lymphatic Leukaemia
Chronic Lymphatic Leukaemia
 
Modern classification of lymphomas (2010) VEAB presentation
Modern classification of lymphomas (2010) VEAB presentationModern classification of lymphomas (2010) VEAB presentation
Modern classification of lymphomas (2010) VEAB presentation
 
Peripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in TreatmentPeripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in Treatment
 
Peripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in TreatmentPeripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in Treatment
 
Peripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in TreatmentPeripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in Treatment
 
Peripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in TreatmentPeripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in Treatment
 
Peripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in TreatmentPeripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in Treatment
 
Peripheral_T_Cell_Lymphomas_Progress_in.pdf
Peripheral_T_Cell_Lymphomas_Progress_in.pdfPeripheral_T_Cell_Lymphomas_Progress_in.pdf
Peripheral_T_Cell_Lymphomas_Progress_in.pdf
 
Peripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in TreatmentPeripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in Treatment
 
Peripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in TreatmentPeripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in Treatment
 
Peripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in TreatmentPeripheral T-Cell Lymphomas: Progress in Treatment
Peripheral T-Cell Lymphomas: Progress in Treatment
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
 
CLL - TSH Midyear 2009
CLL - TSH Midyear 2009CLL - TSH Midyear 2009
CLL - TSH Midyear 2009
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
 

More from spa718

1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai
spa718
 

More from spa718 (20)

1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai
 
Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancer
 
Pancreatic Cancer
Pancreatic CancerPancreatic Cancer
Pancreatic Cancer
 
Chemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancerChemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancer
 
Cholangiocarcinoma
CholangiocarcinomaCholangiocarcinoma
Cholangiocarcinoma
 
Immunotherapy for Colorectal Cancer
Immunotherapy for Colorectal CancerImmunotherapy for Colorectal Cancer
Immunotherapy for Colorectal Cancer
 
Surgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung CancerSurgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung Cancer
 
Role of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung CancerRole of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung Cancer
 
Update on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast CancerUpdate on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast Cancer
 
Technical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) CancerTechnical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) Cancer
 
Controversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast CancerControversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast Cancer
 
ImmunoOncology in Lung Cancer
ImmunoOncology in Lung CancerImmunoOncology in Lung Cancer
ImmunoOncology in Lung Cancer
 
Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015
 
Updates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast CancerUpdates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast Cancer
 
Regulatory T Cells and GVHD
Regulatory T Cells and GVHDRegulatory T Cells and GVHD
Regulatory T Cells and GVHD
 
Immunotherapy for Multiple Myeloma
Immunotherapy for Multiple MyelomaImmunotherapy for Multiple Myeloma
Immunotherapy for Multiple Myeloma
 
NHL immunotherapy
NHL immunotherapyNHL immunotherapy
NHL immunotherapy
 
AML and Cell Therapy
AML and Cell TherapyAML and Cell Therapy
AML and Cell Therapy
 
Acute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment UpdateAcute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment Update
 

Recently uploaded

Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
AnaAcapella
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Recently uploaded (20)

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 

DIAGNOSTIC AND TREATMENT DILEMMAS IN NHL=PART 2

  • 1. Bone Marrow Biopsy  Focal involvement by small B-cell neoplasm without significant plasmacytic differentiation (CD3-, CD20+, PAX5+, kappa IHC-, lambda IHC-, CD5-, CD10-, BCL6-, BCL2+, cyclin D1-, IgD-, Ki67 low) Courtesy of T Pongpruttipan, MD.
  • 2. Review of Colonic Polyp Biospy Tissue HE CD20 HE HE Courtesy of T Pongpruttipan, MD.
  • 3. Final Pathological Diagnosis  Involvement by small B-cell lymphoid neoplasm with CD10+, BCL2+, BCL6- phenotype. No evidence of large cell involvement.  Some small and large cells showed large aggregates with infiltrative growth pattern.  IMP: follicular lymphoma with focus of large cell transformation  DDx  DLBCL with accompanying follicular lymphoma  Follicular lymphoma, grade 3/3 (focal) in the background of follicular lymphoma, low grade
  • 4. Colorectal Lymphoma  A type of extranodal lymphoma involving GI tract  Primary GI lymphoma  Stomach 40-50%  Small bowel 20-30%  Colon and rectum 10-20%  Primary GI lymphoma  No palpable, superficial LN  No enlarged mediastinal LN on CXR  Normal WBC (No and differential count)  Only regional LN involved  No involvement of liver and spleen Dawson IM, et al. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 1961;49:80-9.
  • 6. Musshoff Modifications to Ann Arbor Staging System for Extranodal Lymphoma Stage I or IE Single lymphatic organ or extranodal site II Two or more lymphatic regions on the same site of the diaphragm or a single extranodal organ and lymph node involvement at the same site of diaphragm II1 Regional lymph node involved II2 Distant lymph node involved III Lymph node involved on both sides of diaphragm IV Disseminated disease with involvement of bone marrow, liver, etc Musshoff K. Strahlentherapie 1977;153:218-21. Boot H. Best Pract Res Clin Gastroenterol 2010;24(1):3-12.
  • 7. Common Types in Colorectal NHL  DLBCL 60%  de novo  Transformation from CLL, follicular lymphoma, MALT  MALT 15%%  Burkitt 15  Recent report from Terada T, Japan  37 cases of GI lymphoma  M:F 20:17  Median age 69 yr (46- 89)  Types  Gastric 25 (68%)  Small bowel 6 (16%)  Colon 6 (16%) Terada T. Gastrointestinal malignant lymphoma: a pathologic study of 37 cases in a single Japanese institution. Am J Blood Res 2012;2(3):194-200.
  • 8. Gastrointestinal Lymphoma  Types  B-cell 35 (95%)  T-cell 2 (5%)  Gastric NHL 25  DLBCL 11  MALT 14  Small intestine  DLBCL 4  PTCL 2  Colon 6  DLBCL 5  FL 1  Clinical diagnosis of colon NHL at first  GIST 1  Colon carcinoma 4  Colon polyp 1  No cases of  Hodgkin lymphoma  Burkitt lymphoma  Mantle cell lymphom Terada T. Gastrointestinal malignant lymphoma: a pathologic study of 37 cases in a single Japanese institution. Am J Blood Res 2012;2(3):194-200.
  • 9. Primary FL of GI tract: Massachusetts General Hospital, 1995-2010  Excluded cases  History of FL outside GI tract  Widespread lymphoma  Distant nodal disease within 6 months  Multifocal diseases  Splenic involvement  FL in transformation Misdraji J, et al. Primary follicular lymphoma of the gastrointestinal tract. Am J Surg Pathol 2011;35:1255-63.
  • 10. Presenting Symptoms/ Finding  Symptoms  Abdominal pain and nausea, vomiting (12),  bowel obstruction  Intussuspection (1)  Incidental finding (13) on investigation of  Reflux symptoms or Barrett esophagus  Screening for colorectal cancer  Resection of sigmoid carcinoma  Macroscopic findings  White patches or plaques  Mucosal nodularity or granularity  Nodules  Polyp (1, 2, 3)  Submucosal mass  Thickening of wall or folds Misdraji J, et al. Primary follicular lymphoma of the gastrointestinal tract. Am J Surg Pathol 2011;35:1255-63.